TuskWise

Why don't elephants get cancer?

Published 30 October 2026 · Last reviewed 30 October 2026 · By the TuskWise editorial team

Elephants do get cancer, but much less often than you would expect for an animal with trillions more cells than a person and a lifespan of sixty years or more. A 2015 study estimated that fewer than 5% of elephants die of cancer, compared with 11 to 25% of humans. The leading explanation is genetic: elephants carry at least 20 copies of TP53, a gene that guards against cancer, and their damaged cells tend to self-destruct before they can turn into tumours.

Photorealistic AI-generated image of an old African elephant with wrinkled skin and worn tusks at dusk.
AI-generated illustrative image, not a photograph of a real event. Source.

The short answer

Elephants are not immune to cancer, but they are remarkably resistant to it. An adult African elephant can weigh as much as 100 people and live for six decades, so it has vastly more cells dividing for many more years than we do. Every cell division is a small chance for a mutation that could start a tumour, so on paper elephants should be riddled with cancer. They are not. The best evidence points to an unusual set of genetic defences, led by extra copies of a cancer-fighting gene called TP53.

Peto's paradox: the puzzle of big animals

In 1975 the epidemiologist Richard Peto and colleagues published work on cancer and ageing in mice and people, and Peto later pointed out a striking mismatch. A human has around a thousand times more cells than a mouse and lives roughly thirty times longer, yet people do not get cancer thousands of times more often. Across species, cancer risk simply does not climb with size and lifespan the way the arithmetic predicts. This became known as Peto's paradox.

For years the paradox rested on patchy data. In 2022 a team led by Orsolya Vincze published the largest test so far in Nature, using records from 110,148 adult zoo mammals across 191 species. They found cancer is common across mammals, and that carnivores, especially those that eat other mammals, faced the highest cancer mortality. But they also showed that cancer deaths were largely independent of both body mass and adult life expectancy. Big, long-lived species have evolved ways to keep cancer in check, and elephants are the classic example.

How rare is cancer in elephants?

A 2015 study in JAMA, led by Lisa Abegglen and Joshua Schiffman at the University of Utah, compared necropsy data across 36 mammal species and examined 644 recorded elephant deaths. They estimated elephant cancer mortality at about 4.81%. For comparison, between 11% and 25% of people die of cancer. Across the mammals they studied, cancer mortality did not rise with body size or maximum lifespan.

The picture is not identical for every elephant. A 2021 study in Molecular Biology and Evolution, which pooled pathology records from 26 zoos, found that Asian elephants had a higher prevalence of tumours, including malignant ones, than African bush elephants. Asian elephants are also more vulnerable to tuberculosis and to elephant endotheliotropic herpesvirus, and the authors linked these differences to how each species regulates its immune and inflammatory responses. You can compare the species in our African vs Asian elephant guide.

Twenty copies of the guardian gene

The TP53 gene makes a protein called p53, often nicknamed the guardian of the genome. When a cell's DNA is damaged, p53 can halt the cell so it can make repairs, or order it to die by apoptosis, a tidy form of programmed cell death. People with only one working copy of the gene, a condition called Li-Fraumeni syndrome, have a very high lifetime risk of cancer.

Humans carry one copy of TP53, which means two alleles, one from each parent. The 2015 study found that African elephants carry at least 20 copies, or 40 alleles: the original gene plus 19 extra copies known as retrogenes, with evidence that some of them are actively switched on. A 2016 paper in eLife by Michael Sulak, Vincent Lynch and colleagues traced the history of these copies and found that the number grew around the same time as elephant ancestors evolved very large bodies. Their experiments suggested the extra copies make elephant cells more sensitive to DNA damage and quicker to trigger apoptosis.

Cells that choose to die

The JAMA team tested this in the lab using white blood cells from elephants, healthy people and people with Li-Fraumeni syndrome. After a dose of radiation, about 14.6% of elephant cells went into apoptosis, compared with about 7.2% of cells from healthy people and 2.7% from Li-Fraumeni patients. With the chemotherapy drug doxorubicin, elephant cells again died about three times as often as human cells (24.8% vs 8.1%). The amount of DNA damage was similar; the difference was the response. Elephant cells seem to take a strict line: if the DNA is badly damaged, the safest option is to remove the cell before it can divide into a tumour.

A "zombie" gene comes back to life

p53 does not work alone. In 2018 Juan Manuel Vazquez and colleagues reported in Cell Reports that elephants have several copies of a gene called LIF, most of which are broken. One of them, LIF6, had been a non-working pseudogene in the elephant lineage but regained a function. In elephant cells, p53 switches LIF6 on after DNA damage, and it helps push the damaged cell towards apoptosis. Because a dead gene came back to life, the researchers called it a zombie gene. Together, extra TP53 copies and a revived LIF6 form a layered defence.

What scientists still don't know

These findings are exciting but not the full story. The cancer estimates rely mostly on records from zoo and captive elephants, because wild elephants that die are rarely examined in detail. Body size, metabolism, immune function and other genes probably play a part too; the 2021 genome study found fast-evolving regions linked to immunity and inflammation. Researchers also study elephant genes in the hope of understanding cancer suppression better in people, but that work is at an early stage and is not a treatment. This page is general science, not medical advice.

The bottom line

Elephants should get more cancer than almost any land animal, yet they get less than we do. Extra copies of the TP53 guardian gene, a revived LIF6 zombie gene and cells that readily self-destruct when damaged all help explain why. That resistance is part of what lets elephants grow so large and live so long. For more on elephant bodies, see our elephant anatomy guide, read how much an elephant weighs, or browse the elephant FAQ.

Frequently asked questions

Do elephants ever get cancer?

Yes, but rarely for their size. A 2015 analysis of 644 recorded elephant deaths estimated cancer mortality at about 4.81%, while roughly 11 to 25% of people die of cancer. Tumours have been recorded in zoo elephants, and a 2021 study found Asian elephants have a higher rate of tumours than African bush elephants.

What is Peto's paradox?

Peto's paradox is the puzzle that big, long-lived animals do not get more cancer than small, short-lived ones, even though every extra cell and every extra year is another chance for a cancer-causing mutation. It is named after the epidemiologist Richard Peto. A 2022 Nature study of more than 110,000 zoo mammals found cancer deaths were largely independent of body mass and life expectancy across species.

How many copies of TP53 do elephants have?

Humans have one copy of the TP53 gene (two alleles). African elephants have at least 20 copies (40 alleles): the original gene plus 19 extra copies called retrogenes, several of which are switched on. A 2016 eLife study found the number of copies grew during the same period that elephant ancestors evolved large bodies.

What does TP53 do?

TP53 makes the p53 protein, sometimes called the guardian of the genome. When a cell's DNA is damaged, p53 can pause the cell so it can repair the damage, or tell it to die by apoptosis (programmed cell death). Removing damaged cells early stops them from multiplying into a tumour.

What is the zombie gene in elephants?

LIF6 is a copy of the LIF gene that had been a dead, non-working pseudogene in elephant ancestors. A 2018 study in Cell Reports found it came back to life: in elephant cells, p53 switches LIF6 on after DNA damage, and it helps trigger the death of the damaged cell. The researchers called it a zombie gene.

Can elephant genes cure cancer in people?

Not directly, and not yet. Researchers study elephant TP53 and LIF6 to understand how nature suppresses cancer, which could inspire new ideas for treatment. This article is general science, not medical advice; anyone with health questions should speak to a doctor.

Sources

  1. Peto, R., Roe, F. J. C., Lee, P. N., Levy, L. and Clack, J. (1975). Cancer and ageing in mice and men. British Journal of Cancer 32(4), 411 to 426. DOI 10.1038/bjc.1975.242
  2. Abegglen, L. M., Caulin, A. F., Chan, A. and colleagues (2015). Potential mechanisms for cancer resistance in elephants and comparative cellular response to DNA damage in humans. JAMA 314(17), 1850. DOI 10.1001/jama.2015.13134
  3. Sulak, M., Fong, L., Mika, K. and colleagues (2016). TP53 copy number expansion is associated with the evolution of increased body size and an enhanced DNA damage response in elephants. eLife 5, e11994. DOI 10.7554/eLife.11994
  4. Vazquez, J. M., Sulak, M., Chigurupati, S. and Lynch, V. J. (2018). A zombie LIF gene in elephants is upregulated by TP53 to induce apoptosis in response to DNA damage. Cell Reports 24(7), 1765 to 1776. DOI 10.1016/j.celrep.2018.07.042
  5. Tollis, M., Ferris, E., Campbell, M. S. and colleagues (2021). Elephant genomes reveal accelerated evolution in mechanisms underlying disease defenses. Molecular Biology and Evolution 38(9), 3606 to 3620. DOI 10.1093/molbev/msab127
  6. Vincze, O., Colchero, F., LemaƮtre, J.-F. and colleagues (2022). Cancer risk across mammals. Nature 601, 263 to 267. DOI 10.1038/s41586-021-04224-5

Cite this page

Last reviewed 30 October 2026. Suggested citations for students and teachers:

APA
TuskWise. (2026, October 30). Why don't elephants get cancer? https://tuskwise.com/blog/why-dont-elephants-get-cancer.html

MLA
“Why don't elephants get cancer?” TuskWise, 30 Oct. 2026, tuskwise.com/blog/why-dont-elephants-get-cancer.html.

Chicago
TuskWise. “Why don't elephants get cancer?” TuskWise. Last modified October 30, 2026. https://tuskwise.com/blog/why-dont-elephants-get-cancer.html.

Using a fact from a study? Cite the original paper too. The research page lists the peer reviewed papers behind TuskWise with DOIs.